AMETEK (NYSE:AME) Updates Q3 2026 Earnings Guidance

AMETEK (NYSE:AME) issued an update on its third quarter 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 2.080-2.100 for the period, compared to the consensus EPS estimate of 2.040. The company issued revenue guidance of -, compared to the consensus revenue estimate of $2.0 billion. AMETEK also updated its FY 2026 guidance to 8.200-8.300 EPS.

AMETEK Price Performance

NYSE:AME traded up $0.34 during mid-day trading on Thursday, hitting $255.10. The company’s stock had a trading volume of 49,143 shares, compared to its average volume of 1,278,110. The company has a current ratio of 1.21, a quick ratio of 0.72 and a debt-to-equity ratio of 0.09. The stock has a fifty day moving average of $235.01 and a 200-day moving average of $229.47. The company has a market capitalization of $58.47 billion, a price-to-earnings ratio of 37.29, a P/E/G ratio of 3.50 and a beta of 0.98. AMETEK has a fifty-two week low of $179.24 and a fifty-two week high of $257.95.

AMETEK (NYSE:AME) last announced its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $1.95 billion. During the same period last year, the firm posted $1.78 EPS. The firm’s quarterly revenue was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. As a group, equities analysts forecast that AMETEK will post 8.27 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Mizuho set a $270.00 price target on AMETEK in a research note on Friday, May 1st. Citigroup boosted their price target on shares of AMETEK from $257.00 to $261.00 and gave the company a “neutral” rating in a report on Wednesday. DA Davidson boosted their target price on AMETEK from $265.00 to $285.00 and gave the company a “buy” rating in a research note on Wednesday. Truist Financial lifted their price objective on AMETEK from $275.00 to $303.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Finally, Royal Bank Of Canada lifted their price target on shares of AMETEK from $260.00 to $291.00 and gave the company an “outperform” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $265.93.

AMETEK News Roundup

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Quarterly earnings beat expectations: AMETEK reported second-quarter 2026 revenue of $2.04 billion, up 15% year over year and above the $1.95 billion consensus estimate. Adjusted earnings per share rose 17% to $2.09, exceeding expectations by $0.10, with stronger sales in its EIG and EMG businesses. AMETEK Q2 Earnings Surpass Expectations, Revenues Rise Year over Year
• Positive Sentiment: Higher outlook reinforces the earnings catalyst: Management raised or established 2026 guidance at $8.20-$8.30 in EPS, while third-quarter guidance calls for $2.08-$2.10 per share. Analysts currently expect full-year EPS of approximately $8.27. AMETEK’s Q2 CY2026: Strong Sales
• Positive Sentiment: Analysts raised price targets: DA Davidson lifted its target from $265 to $285 and assigned a “buy” rating. BNP Paribas Exane raised its target from $270 to $280 and maintained an “outperform” rating. The upgrades signal continued confidence in AMETEK’s growth and execution. AMETEK Reaches New 12-Month High Following Analyst Upgrade
• Positive Sentiment: New product supports growth prospects: AMETEK introduced the Grabner Vision Pro Series, a fuel-analysis product designed to provide improved performance and potentially expand demand in industrial testing markets. AMETEK Introduces Grabner Vision Pro Series

Hedge Funds Weigh In On AMETEK

A number of hedge funds have recently added to or reduced their stakes in the stock. Darwin Wealth Management LLC acquired a new stake in shares of AMETEK during the 2nd quarter worth $25,000. Transamerica Financial Advisors LLC grew its stake in AMETEK by 73.9% during the fourth quarter. Transamerica Financial Advisors LLC now owns 153 shares of the technology company’s stock worth $31,000 after buying an additional 65 shares in the last quarter. DV Equities LLC acquired a new position in shares of AMETEK in the 4th quarter valued at approximately $66,000. Johnson Financial Group Inc. lifted its holdings in shares of AMETEK by 17.4% during the 3rd quarter. Johnson Financial Group Inc. now owns 478 shares of the technology company’s stock worth $90,000 after acquiring an additional 71 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in shares of AMETEK during the 3rd quarter worth approximately $92,000. Institutional investors own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.